Agios Pharmaceuticals lobbies on its own behalf. For Q3 2026 it reported $30K across 1 client report and lists 1 lobbyist across its filings. Issues include Health Issues, Medical/Disease Research/Clinical Labs and Medicare/Medicaid.
| Client | Reported | Issues |
|---|---|---|
| AGIOS PHARMACEUTICALS | $30K | Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $130K | 1 |
| 2025 | $50K | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.